Quercis Pharma

Executive Summary

Quercis Pharma is a Swiss biopharmaceutical company founded in 2014, dedicated to developing small molecule therapies for global health challenges with a mission to 'Heal the World.' The company emphasizes patient-centricity and equitable access to safe, effective, and affordable medicines. Operating as a private entity from its headquarters in Zug, Quercis Pharma has not yet disclosed specific pipeline details or financials, but its focus on small molecules positions it in a competitive landscape. Given the limited publicly available information, the company's progress and near-term prospects remain uncertain, though its mission-driven approach may attract partnerships or funding to advance its preclinical or clinical programs. The lack of disclosed milestones or commercial products suggests early-stage operations, and any near-term catalysts would likely emerge from pipeline advancements or financing events.

Upcoming Catalysts (preview)

• Q3 2026Phase 2 Clinical Trial Readout for Lead Candidate30% success
• Q4 2026Series B or C Financing Round Announcement50% success
• TBDStrategic Partnership or Licensing Deal40% success